Affidea

In celebration of Mental Health Month, Affidea has kicked off an exciting Monthly #WalkingChallenge – an international competition that brings together 15 country teams and the Corporate Office. Together, we’re stepping out, staying #active, and embracing a little friendly competition. Our collective goal? To walk 538,160,000 steps – the distance from Earth to the Moon 🌕 (that’s 384,400 km)! After just one week of the challenge, we’ve already walked an incredible 101,939,665 steps! Nearly 2,000 Affidea people are on this journey, and the results are astounding. Here’s a glimpse of the top achievements after the first week: Top Individual Walkers: 1️⃣ Alexandru Nimara (Affidea Romania) – 598,463 steps (85,495 steps/day) said - “It is a mental game in which you must learn to fight your inner demon. My secret is to focus on the next step”. 2️⃣ Clark Sabela (Affidea Ireland) – 597,714 steps (85,388 steps/day) said - “I try to run every morning 5km-10km, at work I always go for a walk during break time and after work once home I try to walk or run again in the evening”. 3️⃣ @Sergio Martin (Affidea Spain) – 561,850 steps (80,264 steps/day). Sergio recommends reading Haruki Murakami’s book “18 `Til I Die“ and accompanying it with the same song from Bryan Adams “18 Till I Die”. Sergio says:  “Haruki Murakami, the famous novelist and marathon runner, teaches us this idea. It's not just about youth but embracing every moment with energy and passion”. Top Countries by Steps: 🔝Affidea Czech Republic leads with an impressive average of 111,361 steps per participant! 🔝Affidea Portugal logged a whopping 17,391,752 steps from 337 participants! The WHO recommends at least 10,000 steps/day to stay healthy. Our top walkers are doing over 8.5 times that amount – simply amazing! Let’s keep up the momentum and step towards a healthier, more active lifestyle! 💙 #MentalHealthMonth #AffideaWalkingChallenge #StepToTheMoon #StrongerTogether

We are delighted to announce that Affidea has successfully completed the acquisition of Nu-Med Group, a well-established and reputed #cancercare provider in Poland. Through this step, we aim to provide a holistic approach to cancer care, from prevention and early diagnosis to advanced treatment, ensuring that patients benefit from a comprehensive and coordinated care pathway. This is the third significant investment in cancer care that Affidea has made in over last the two years, including our expansion in Switzerland with Brust Zentrum Zurich, and Romania with MedEuropa radiotherapy centres, and it brings Affidea’s network to 374 centres across Europe. “By integrating Nu-Med’s expertise into our pan-European network, oncology services now represent a quarter of Affidea’s business, working symbiotically with our broader diagnostic and outpatient centres. In Poland, we work in partnership with the NFZ (Polish National Health Fund) to offer faster and better access to high-quality cancer care services and diagnostics. Due to our scale, we are very well positioned to create an advanced platform of #care that transcends national borders, ensuring that patients across Europe benefit from the highest standards of care, targeting better clinical #outcomes, and improved #access at a local level,” commented Guy Blomfield, Affidea CEO and Chairman of the Management Board. "The integration of Nu-Med into the Affidea network is a major milestone in expanding our established cancer care footprint in Poland. We are excited to welcome Nu-Med’s talented professionals, whose dedication and expertise are well-recognised across the country. This acquisition reinforces our commitment to the National Oncology Strategy, ensuring patients benefit from the highest standards of care - from #prevention and #earlydiagnosis to comprehensive #treatment. Together, we will build on our strengths to improve cancer survivorship outcomes," added Mesut Goral, President of the Management Board and CEO of Affidea Poland, Senior Vice President and COO of Affidea Group. Read more on our website: https://lnkd.in/d872WPtS

We are delighted to announce that @Maria Conceição Antunes has been named Affidea's European Employee of the Month for September 2024! Maria, one of our dedicated receptionists at a blood collection point of Affidea Portugal, truly stands out for her exceptional dedication, proactivity, and friendliness. Her warmth and attention, especially toward the elderly population in rural areas who face greater difficulties with technology, have made a significant difference in the care she provides. The award was presented to Maria during the Affidea Medical Council in September, held in beautiful Casçais, Portugal. She received the recognition from Dr Charles Niehaus, Executive Director for Affidea Group,Miguel Santos, CEO Affidea Portugal, Eduardo Blazquez Gomez, Chief HR Officer, Sérgio Bio Fernandes, Country Operations Director Laboratories, and Ana Marques, HR Director Affidea Portugal. Congratulations, Maria! We are proud to have you on our team! #EmployeeOfTheMonth #ExcellenceInCare

Affidea is proud to participate in the #EUSOBI Congress in Lisbon, where the latest advancements in #breastimaging take centre stage. We are committed to enhancing the breast care pathway for women, with a focus on integrating cutting-edge imaging techniques and AI solutions into our clinical practice to improve clinical outcomes. At Affidea, our experts are always leading the way in innovation. They actively share insights at important European congresses and bring back the latest knowledge to continuously improve patient care. This year's focus on AI and new applications in breast imaging at #EUSOBI2024 aligns perfectly with our dedication to providing women with personalised solutions for their healthcare journey. We're happy to have a part of our clinical team representing Affidea at #EUSOBI2024, including Javier Azcona Sáenz, Rosana Santos, @Sílvia Rodríguez, @Rocco Barone and our sub-speciality experts on breast imaging - Pilar Manchón Gabás and @Ruta Briediene. #EUSOBI2024 #BreastCare #InnovationInHealthcare #BreastImaging #WomensHealth #PatientCare 

Affidea Scientific Talks opens up a new exciting webinar - “Critical Findings in Abdominal Imaging – Expect the Unexpected", taking place on October 14th, 2024, at 1 pm CET! 🗓️ We are delighted to announce that the webinar received CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME®). Did you know that critical findings in outpatient imaging studies are more common than you might expect? Due to their urgency or significance, these findings often require immediate communication with the referring physician, making them crucial to the patient’s outcome. Join us for an engaging session with Prof. Palko Andras and Prof. @Giuseppe Brancatelli, two internationally renowned experts, as they present fascinating cases that reveal more than meets the eye. From subtle yet significant findings to true diagnostic challenges, this webinar will explore how these insights can influence patient management. The webinar is open to all, and registration is free for Affidea staff! Don’t miss out! Register now and secure your spot today. Register here and learn more about the webinar: https://lnkd.in/de5iunqV #AffideaWebinar #AbdominalImaging #MedicalEducation #PatientCare #ExpertTalks Alessandro Roncacci, Ines Ferreira, Rosana Santos

Inspiring days at the Annual #Marketing Meeting in beautiful Cascais, Portugal!  It was a perfect blend of #creativethinking, #strategicplanning and team #engagement activities as our marketing teams came together to share best practices, learn from each other, and explore new innovative tools to support the business growth. An important workshop was about the evolution of the Affidea brand, which is growing alongside our business, reinforcing our commitment to delivering patient-centered #care. #AI is becoming a key topic, which is transforming not only our clinical practices but also our marketing approach. In a rapidly digitalising world, connecting with patients and referring doctors in a personalised, meaningful way has never been more important. Our team explored solutions that will enhance the patient experience, adding value at every touchpoint of their healthcare journey. Exciting times ahead as we continue to innovate and bring our brand closer to the communities we serve! Guy Blomfield, Chairman of the Management Board and Affidea CEO, commented: "Quality care goes beyond clinical excellence—it’s about understanding and delivering the outcomes that matter to our patients while providing service excellence, better #access, and cost efficiency. Whether it's improving their health and well-being, providing clarity in diagnosis, or ensuring a smooth patient experience, we focus on what truly impacts their lives. Our marketing teams play a vital role in this, ensuring that we communicate effectively and meaningfully at every touchpoint. By leveraging data and advanced technologies, we not only support patients throughout their healthcare journey but also empower them to feel confident in the choices they make." Oana Dumitroiu, Senior Vice-President on Marketing, commented: “In healthcare, patient experience is paramount, and at Affidea, we strive to create a journey where every touchpoint is tailored, seamless and adds value. We are continuously evolving our marketing strategies to leverage new technologies, such as AI, to deliver personalised, relevant information that empowers patients to make informed decisions while also strengthening our relationships with referring doctors. Our goal is to be a partner in their healthcare decisions, creating meaningful connections and providing the guidance patients need to feel truly cared for throughout their journey”. With: Ines Ferreira, Jacinta Oliveira Rodrigues, Chryssa Spyropoulou, Vesta Krungolciene, Viktorija Ulinskė, Austeja Simanaviciute, Anca Ghelbere, Andrzej Szczepłocki, Yigit Tugrul Tokman, Caroline Büchler, Francesca Ginocchi, Muireann Feirtéir, Álvaro Pérez Meliá, Alexandra Kollar,

This past weekend, the Affidea Annual Medical and Quality Meeting took place in beautiful Cascais, bringing together an exceptional group of professionals. Dr Charles Niehaus, Executive Director for Affidea Group, stated: "It’s inspiring to see the level of commitment of our Medical Leaders who joined this event. Their engagement is essential as we continue to advance innovation, particularly through our digital strategy and #AI projects, which are enhancing #patientcare and driving better clinical outcomes."   Alessandro Roncacci, SVP Chief Medical Officer of Affidea, commented: “Affidea’s success sits in the integration of clinical safety, quality, education, and innovation. This event highlights our commitment to pushing the boundaries of patient care, driving collaboration, and sharing knowledge to ensure we continue to lead the way in healthcare."    Guy Blomfield, Chairman of the Management Board and Affidea Group CEO, commented: “I am always humbled by the commitment, passion and collective capability of our clinical and broader Affidea teams that attended this important annual forum - this year being over 100 colleagues from across our Europe-wide footprint. The primacy of our clinical governance leadership is the key enabler of our growth strategy to develop community-based polyclinics and Centres of Excellence. It is evident that quality and standardisation are embedded in every aspect of what we do. This allows us to deliver high-quality care and improve patient outcomes in our evolving healthcare landscape, where patients choose their providers by demanding evidence of both service and clinical quality.”   Main topics focused on:   Vision Guy Blomfield and Charles Niehaus shared Affidea’s strategy and emphasised the important roles that Clinical, Quality, and Marketing functions play in supporting our business growth.   Clinical Governance & Quality Athanasia Papachristodoulou announced the new KPIs to monitor #quality and #safety standards in our centres, and presented the new digital Quality Management System together with Nicole David and Karla Santana.   Dose Management & Service Development Chryssa Paraskevopoulou introduced the advancements in #DoseExcellence Project and presented the new #ContrastMediaManagement Project. Clodoaldo D. Filho and Rocco Barone shared updates on Integrated Care Pathways and AI projects.   Oncology Workshop We delved into Women’s Care, Radiation Oncology, Nuclear Medicine, and Technological advancements in #CancerCare with the contributions of @Patriciu Achimas, Philip Poortmans, Miroslaw Dziuk, and Dee Mathieson from Elekta.   Operations & Professional Development Mesut Goral spoke about what drives productivity in our centres, while Rosana Santos presented Affidea’s CME-accredited webinars and the new #AffideaAcademy. Mahen HOOLASH from GE HealthCare, with Eduardo Blazquez Gomez and Ara Estebaranz, led an engaging workshop on #Leadership, to attract and retain clinical talents.

We are delighted to announce that Affidea expands in Lithuania, adding laboratory services to its local network through the acquisition of SYNLAB Lithuania. "The acquisition of SYNLAB is a significant milestone in our strategic expansion in Lithuania. By integrating SYNLAB’s specialized laboratory services with our existing outpatient network, we can deliver a full spectrum of services, from advanced diagnostics to specialised laboratory tests, close to the communities we serve", said Vitalijus Orlovas, Affidea Lithuania CEO. Guy Blomfield, Affidea Group CEO and Chairman of the Management Board, completed: “The acquisition of SYNLAB Lithuania is an important step in our expansion plan in Lithuania where we built a network of community-based polyclinics, offering integrated healthcare services. This decision reinforces our commitment to delivering accessible, high-quality services that meet the evolving needs of the communities we serve". We invite you to read more on the press release below.

We are thrilled to announce that Konstantina Karathanasi has been selected as our European Employee of this month! 👏 Konstantina has consistently demonstrated #excellence as a Call Center agent, standing out with her exceptional commitment to #patientsatisfaction. She works tirelessly with our doctors and various departments to ensure a seamless experience for our patients. Her #dedication to finding effective solutions has earned her high praise both internally and from our patients. Beyond her professionalism, Konstantina is admired for her outstanding teamwork and passion for serving our patients. Congratulations, Konstantina, we are happy to have you in our team! This recognition took place at our Affidea Kallithea centre, with the award being presented by Theodoros Karoutzos, Affidea Greece Country CEO, Eirini Anagnostopoulou, Greece HR Director, and Maria F. K., Affidea Kallithea Center Manager.

We are delighted to announce that Affidea has entered into a binding agreement to acquire Nu-Med, a renowned cancer care provider in Poland, which operates four medical centres across Poland: Elbląg (North), Katowice (South), Tomaszów Mazowiecki (centre), and Zamość (East). Completion of the acquisition is subject to the approval of the Polish Office of Competition and Consumer Protection. The acquisition complements Affidea’s existing cancer care portfolio in Poland and will allow the two companies to further improve patient access to integrated cancer services. Guy Blomfield, Affidea Group CEO and Chairman of the Management Board, commented: "I very much welcome Nu-Med’s reputable medical, management and administrative team to the Affidea community and look forward to building upon our already strong foundation of care, ensuring that patients across the country continue to receive the highest standards of care. Together, Affidea and Nu-Med share a commitment to clinical excellence, and this partnership will play an important role in improving early detection, diagnosis, and access to cutting-edge radiotherapy services in community settings throughout Poland.” Read more in the article below.